Study of hesperetin effect on modulating transcription levels of MLH1 and MSH2 genes in SKBR3 breast cancer cell line

Study of hesperetin effect on modulating transcription levels of MLH1 and MSH2 genes in SKBR3 breast cancer cell line

Hesperetin (HSP), a flavonoid, has been validated to modify gene expression and function as an epigenetic agent to stop the development of breast carcinoma cells. HSP was investigated in this research to evaluate the expression of the MLH1 and MSH2 genes in cancerous breast cell lines (SKBR3) and he...

Full description

Bibliographic Details
Main Authors:	Naser Hameed Saleh, Ahmed Salim Kadhim Al-Khafaji, Esmaeil Babaei
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Journal of Advanced Pharmaceutical Technology & Research
Subjects:	3-(4 5-dimethylthiazol-2-yl)-2 5-diphenyltetrazolium bromide test apoptosis cytotoxicity flow cytometry half-maximal inhibitory concentration 50 hesperetin malignancy mlh1 gene expression msh2 gene expression
Online Access:	http://www.japtr.org/article.asp?issn=2231-4040;year=2023;volume=14;issue=4;spage=338;epage=344;aulast=Saleh

Similar Items

Exploring the modulation of MLH1 and MSH2 gene expression in hesperetin-treated breast cancer cells (BT-474)
by: Ahmed Mohammed Salman, et al.
Published: (2024-01-01)

Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549
by: Assim Khattab Hasan, et al.
Published: (2023-01-01)

Evaluation of Cytotoxic Effect of Different Extracts of Seidlitzia rosmarinus on HeLa and HepG2 Cell Lines
by: Behzad Zolfaghari, et al.
Published: (2018-01-01)

Effects of Juglone on Antioxidant Status in Pancreatic Cancer Cell Lines
by: Emine Nedime Korucu, et al.
Published: (2019-06-01)

In vitro cytotoxic activity of menispermaceae plants against HeLa cell line
by: B Samuel Thavamani, et al.
Published: (2013-01-01)

Cytotoxic activity of endophytes isolated from Allamanda blanchetii A. DC
by: Harsha D Pednekar, et al.
Published: (2019-01-01)

Comparative evaluation of cytotoxic and genotoxic effects of three resin-based sealers by 3,(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and comet assay – an in vitro study
by: Vaidehi Vikas Dhopavkar, et al.
Published: (2021-01-01)

Phytochemical Screening and Cytotoxic Evaluation of Euphorbia turcomanica on Hela and HT-29 Tumor Cell Lines
by: Mehdi Aliomrani, et al.
Published: (2017-01-01)

Novel polyvinyl alcohol film dosimeter containing 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide dye for high dose application
by: Khalid A. Rabaeh, et al.
Published: (2023-09-01)

IMMUNOHISTOCHEMICAL STUDY OF MSH2, MSH6, PMS2, MLH1 IN EVALUATION OF DIFFERENTIATION GRADE OF COLON ADENOCARCINOMA
by: G. A. Raskin, et al.
Published: (2016-02-01)

Exploring the Role of Phytochemicals: Effect of [6]-Gingerol Combined with Colloidal Gold Nanoparticles on Thyroid Carcinoma Cells
by: Majid S. Khalaf, et al.
Published: (2023-03-01)

Characterization of the biological effect of BiodentineTM on primary dental pulp stem cells
by: Nadine Hasweh, et al.
Published: (2018-01-01)

Simultaneous Analysis of MLH1, MSH2, MSH6, PMS2 and KRAS in Patients with Gastric and Colon Cancer Using Stochastic Sensors
by: Damaris-Cristina Gheorghe, et al.
Published: (2022-09-01)

Antibacterial activity of fig leaf (Ficus carica Linn.) extract against Enterococcus faecalis and its cytotoxicity effects on fibroblast cells
by: Intan Nirwana, et al.
Published: (2018-03-01)

Investigation of APC, MLH1 and MSH2 Mutations in Patients with Hereditary Colorectal Carcinoma: A Single Center Experience
by: Mehmet Buğrahan Düz
Published: (2021-01-01)

Evaluation of cytotoxicity of aqueous extract of Graviola leaves on squamous cell carcinoma cell-25 cell lines by 3-(4,5-dimethylthiazol-2-Yl) -2,5-diphenyltetrazolium bromide assay and determination of percentage of cell inhibition at G2M phase of cell cycle by flow cytometry: An in vitro study
by: Visveswaraiah Paranjyothi Magadi, et al.
Published: (2015-01-01)

Rare single‐nucleotide variants of MLH1 and MSH2 genes in patients with Lynch syndrome
by: Seyed Mohsen Mirabdolhosseini, et al.
Published: (2024-01-01)

Patient-Derived Ex Vivo Cultures and Endpoint Assays with Surrogate Biomarkers in Functional Testing for Prediction of Therapeutic Response
by: Yoshiyuki Tsukamoto, et al.
Published: (2023-08-01)

In vitro evaluation of cytotoxicity and corrosion behavior of commercially pure titanium and Ti-6Al-4V alloy for dental implants
by: Sanchitha Chandar, et al.
Published: (2017-01-01)

Cytotoxic activity of kenaf (Hibiscus cannabinus L.) seed extract and oil against human cancer cell lines
by: Yu Hua Wong, et al.
Published: (2014-05-01)

Frequent Novel Variations Within MSH2 and MLH1 Genes in a Subset of Iranian Families With Hereditary Non-Polyposis Colorectal Cancer
by: Shadi Javan, et al.
Published: (2019-05-01)

Different Approaches for Silver Nanoparticle Sterilization for Administration to Cell Culture
by: Aleksandra Zimon, et al.
Published: (2023-06-01)

Določanje polimorfizmov in mutacij v genih MLH1 in MSH2 pri nepolipoznem raku debelega črevesa
by: Vida Stegel, et al.
Published: (2008-12-01)

Prognostic Significance of the Mismatch Repair Gene in Colorectal Cancer Patients Treated with 5-Fluorouracil Chemotherapy.
by: Kanet Kanjanapradit, et al.
Published: (2011-02-01)

Viability test of fish scale collagen (Oshpronemus gouramy) on baby hamster kidney fibroblasts-21 fibroblast cell culture
by: Chiquita Prahasanti, et al.
Published: (2018-04-01)

MLH1 Ile219Val polymorphism in Argentinean families with suspected Lynch syndrome
by: Mev Dominguez-Valentin, et al.
Published: (2016-08-01)

MSH2 Overexpression Due to an Unclassified Variant in 3’-Untranslated Region in a Patient with Colon Cancer
by: Raffaella Liccardo, et al.
Published: (2020-06-01)

No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in <i>MLH1</i> and <i>MSH2</i>: A Prospective Lynch Syndrome Database Study
by: Mev Dominguez-Valentin, et al.
Published: (2021-06-01)

Cytotoxicity of different extracts of arial parts of Ziziphus spina-christi on Hela and MDA-MB-468 tumor cells
by: Abbas Jafarian, et al.
Published: (2014-01-01)

FROM FAMILIES SYNDROMES TO GENES… THE FIRST CLINICAL AND GENETIC CHARACTERIZATIONS OF HEREDITARY SYNDROMES PREDISPOSING TO CANCER: WHAT WAS THE BEGINNING?
by: Charité Ricker, MS, LCGC
Published: (2017-07-01)

Modifier genes and Lynch syndrome: some considerations
by: Rodney J. Scott
Published: (2022-09-01)

Association between colorectal cancer, the frequency of Bacteroides fragilis, and the level of mismatch repair genes expression in the biopsy samples of Iranian patients
by: Nooshin Nazarinejad, et al.
Published: (2024-02-01)

The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care
by: Pål Møller
Published: (2020-03-01)

CTGF and MLH1 Gene Expression Levels in Colorectal Cancer Tumor Tissues and Adjacent Normal Tissues in Patients in Golestan Province
by: Amin Lotfvarzi, et al.
Published: (2023-03-01)

Lynch Syndrome Germline Mutations in Breast Cancer: Next Generation Sequencing Case-Control Study of 1,263 Participants
by: Aleksey G. Nikitin, et al.
Published: (2020-05-01)

Germline MLH1 and MSH6 mutations from two Lynch syndrome families identified in a patient with early-onset of endometrial cancer: A case report
by: Yi-Ching Huang, et al.
Published: (2024-06-01)

The protective effect of hesperetin and nano-hesperetin on object recognition memory in animal model of Alzheimer
Published: (2017-11-01)

Telomere Instability in Lynch Syndrome Families Leads to Some Shorter Telomeres in <i>MSH2+/-</i> Carriers
by: M. Carmen Garrido-Navas, et al.
Published: (2020-10-01)

Gold Nanoparticles Functionalized with 2-Thiouracil for Antiproliferative and Photothermal Therapies in Breast Cancer Cells
by: Génesis Lorenzana-Vázquez, et al.
Published: (2023-05-01)

Cáncer hereditario: fundamentos genéticos
by: Trinidad Caldés
Published: (2005-01-01)